The Tech Edvocate

Top Menu

  • Advertisement
  • Apps
  • Home Page
  • Home Page Five (No Sidebar)
  • Home Page Four
  • Home Page Three
  • Home Page Two
  • Home Tech2
  • Icons [No Sidebar]
  • Left Sidbear Page
  • Lynch Educational Consulting
  • My Account
  • My Speaking Page
  • Newsletter Sign Up Confirmation
  • Newsletter Unsubscription
  • Our Brands
  • Page Example
  • Privacy Policy
  • Protected Content
  • Register
  • Request a Product Review
  • Shop
  • Shortcodes Examples
  • Signup
  • Start Here
    • Governance
    • Careers
    • Contact Us
  • Terms and Conditions
  • The Edvocate
  • The Tech Edvocate Product Guide
  • Topics
  • Write For Us
  • Advertise

Main Menu

  • Start Here
    • Our Brands
    • Governance
      • Lynch Educational Consulting, LLC.
      • Dr. Lynch’s Personal Website
      • Careers
    • Write For Us
    • The Tech Edvocate Product Guide
    • Contact Us
    • Books
    • Edupedia
    • Post a Job
    • The Edvocate Podcast
    • Terms and Conditions
    • Privacy Policy
  • Topics
    • Assistive Technology
    • Child Development Tech
    • Early Childhood & K-12 EdTech
    • EdTech Futures
    • EdTech News
    • EdTech Policy & Reform
    • EdTech Startups & Businesses
    • Higher Education EdTech
    • Online Learning & eLearning
    • Parent & Family Tech
    • Personalized Learning
    • Product Reviews
  • Advertise
  • Tech Edvocate Awards
  • The Edvocate
  • Pedagogue
  • School Ratings

logo

The Tech Edvocate

  • Start Here
    • Our Brands
    • Governance
      • Lynch Educational Consulting, LLC.
      • Dr. Lynch’s Personal Website
        • My Speaking Page
      • Careers
    • Write For Us
    • The Tech Edvocate Product Guide
    • Contact Us
    • Books
    • Edupedia
    • Post a Job
    • The Edvocate Podcast
    • Terms and Conditions
    • Privacy Policy
  • Topics
    • Assistive Technology
    • Child Development Tech
    • Early Childhood & K-12 EdTech
    • EdTech Futures
    • EdTech News
    • EdTech Policy & Reform
    • EdTech Startups & Businesses
    • Higher Education EdTech
    • Online Learning & eLearning
    • Parent & Family Tech
    • Personalized Learning
    • Product Reviews
  • Advertise
  • Tech Edvocate Awards
  • The Edvocate
  • Pedagogue
  • School Ratings
  • Mind-Blowing: These Viral Amazon Products Are NOT What You Expect

  • Bizarre: AI-Generated Fake Health Influencers Are Invading Your Feed – Here’s How to Spot Them

  • Six Startups Launch IPOs in One Day: Is This India’s Most Audacious Bet Yet?

  • The Baffling Twitter Startup Name Change: Why ‘Bluebird’ Had to Die

  • The PlayStation Trump Tariff Refunds You Won’t Get: Why Sony’s Silence Is Infuriating Gamers

  • The White House ‘Arcade’ Scandal: Why the Tetris Controversy Is Just the Beginning

  • The Billion-Dollar Battle: Seattle Times’ AI Lawsuit Could Redefine Digital Rights

  • This OpenAI Pause Reveals a Disturbing Truth About AI’s Future

  • Stunning: Feds Quietly Erase Data on Gender-Based Bullying – What It Means for Vulnerable Students

  • The Raw Truth About the Colorado Student Walkout You Haven’t Heard

Best of the Best Lists
Home›Best of the Best Lists›10 Best Healthcare Stocks to Buy Now

10 Best Healthcare Stocks to Buy Now

By Matthew Lynch
September 5, 2023
0
Spread the love

Investing in the healthcare sector can be a smart decision as it’s a rapidly growing industry with significant advancements in technology and innovation. Here are 10 of the best healthcare stocks to buy now.

1. Johnson & Johnson (JNJ)

Johnson & Johnson is a multinational healthcare company that produces medical devices, pharmaceuticals, and consumer goods. It is well-known for its consistent dividend payments and long-term growth potential.

2. Pfizer Inc. (PFE)

Pfizer is a leading pharmaceutical company that develops and manufactures medications, vaccines, and consumer healthcare products. They recently made headlines with their successful COVID-19 vaccine.

3. Merck & Co., Inc. (MRK)

Merck is known for its diversified portfolio of pharmaceutical products, including treatments for diabetes, cancer, and infectious diseases such as HIV/AIDS.

4. UnitedHealth Group Incorporated (UNH)

UnitedHealth Group offers health insurance and healthcare services through its subsidiaries. They provide plans for individuals, employers, Medicare, and Medicaid beneficiaries.

5. AbbVie Inc. (ABBV)

AbbVie is a research-driven biopharmaceutical company that focuses on discovering new therapies for immune disorders, oncology, and neurology.

6. AstraZeneca PLC (AZN)

AstraZeneca specializes in the research, development, manufacturing, and distribution of prescription drugs used to treat various diseases such as cardiovascular diseases, diabetes, cancer, respiratory illnesses, and autoimmune diseases.

7. Gilead Sciences Inc. (GILD)

Gilead Sciences is a biopharmaceutical company focused on developing antiviral medications and treatments for HIV/AIDS, hepatitis B and C viruses, influenza infections, and cancer.

8. Novo Nordisk A/S (NVO)

Novo Nordisk is a leader in diabetes care with products like insulin pens and glucose monitoring systems. They also develop medications to treat other chronic conditions like obesity, hemophilia, and growth hormone deficiency.

9. Moderna Inc. (MRNA)

Moderna is a biotechnology company that specializes in drug discovery and development based on messenger RNA (mRNA) technology. They were one of the first companies to develop and deploy a COVID-19 vaccine.

10. Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb is a pharmaceutical company with a focus on oncology, cardiovascular diseases, immunology, and fibrosis. Their product portfolio includes drugs such as Opdivo, Eliquis, Revlimid, and Orencia.

Please note that investing in stocks always carries risks, so it’s crucial to conduct thorough research before making any decisions. It’s essential to make individual assessments based on financial goals and risk tolerance before investing in particular stocks.

Previous Article

Call vs Put Options: What’s the Difference?

Next Article

5 Top Metaverse Stocks to Keep an ...

Matthew Lynch

Related articles More from author

  • Best of the Best Lists

    Best Happy New Year Quotes and Messages

    December 3, 2024
    By Matthew Lynch
  • Best of the Best Lists

    Best Gifts for Tweens in 2024

    February 1, 2024
    By Matthew Lynch
  • Best of the Best Lists

    5 Best Printers for Stickers You Can Buy

    February 19, 2024
    By Matthew Lynch
  • Best of the Best Lists

    Best Pillows for Neck Pain

    August 26, 2023
    By Matthew Lynch
  • Best of the Best Lists

    Master the Art of Steak Tacos: Your Ultimate Recipe Guide

    November 23, 2024
    By Matthew Lynch
  • Best of the Best Lists

    Best Smartwatches for Heart Health Monitoring

    November 26, 2024
    By Matthew Lynch

Search

Login & Registration

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Newsletter

Signup for The Tech Edvocate Newsletter and have the latest in EdTech news and opinion delivered to your email address!

About Us

Since technology is not going anywhere and does more good than harm, adapting is the best course of action. That is where The Tech Edvocate comes in. We plan to cover the PreK-12 and Higher Education EdTech sectors and provide our readers with the latest news and opinion on the subject. From time to time, I will invite other voices to weigh in on important issues in EdTech. We hope to provide a well-rounded, multi-faceted look at the past, present, the future of EdTech in the US and internationally.

We started this journey back in June 2016, and we plan to continue it for many more years to come. I hope that you will join us in this discussion of the past, present and future of EdTech and lend your own insight to the issues that are discussed.

Newsletter

Signup for The Tech Edvocate Newsletter and have the latest in EdTech news and opinion delivered to your email address!

Contact Us

The Tech Edvocate
910 Goddin Street
Richmond, VA 23231
(601) 630-5238
[email protected]

Copyright © 2026 Matthew Lynch. All rights reserved.